VANGUARD GROUP INC - JASPER THERAPEUTICS INC ownership

JASPER THERAPEUTICS INC's ticker is and the CUSIP is 471871103. A total of 28 filers reported holding JASPER THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.07 and the average weighting 1.7%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of JASPER THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,655,071
-47.5%
3,792,958
+2.8%
0.00%
Q2 2023$5,053,051
-25.1%
3,688,358
-1.0%
0.00%
Q1 2023$6,744,326
+2533.0%
3,726,147
+602.5%
0.00%
Q4 2022$256,149
-38.7%
530,438
+0.1%
0.00%
Q3 2022$418,000
-55.0%
530,120
+10.3%
0.00%
Q2 2022$928,000
-45.3%
480,561
+0.6%
0.00%
Q1 2022$1,697,000
-55.3%
477,824
-1.2%
0.00%
Q4 2021$3,795,000483,5030.00%
Other shareholders
JASPER THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Qiming U.S. Ventures Management, LLC 5,852,982$20,778,00019.52%
Velan Capital Investment Management LP 3,219,036$10,180,0009.45%
Abingworth LLP 5,628,558$19,531,0005.54%
SECTORAL ASSET MANAGEMENT INC 675,000$2,396,0000.42%
KINGDON CAPITAL MANAGEMENT, L.L.C. 540,000$1,917,0000.20%
Vahanian & Associates Financial Planning Inc. 10,000$36,0000.08%
Forefront Analytics, LLC 32,550$118,0000.04%
Citadel Advisors 2,994,580$10,631,0000.00%
FEDERATED HERMES, INC. 251,697$894,0000.00%
Ionic Capital Management LLC 100$00.00%
View complete list of JASPER THERAPEUTICS INC shareholders